Effect of weight loss on adipokine levels in obese patients

Background: Adipose tissue functions as an endocrine organ by releasing adipokines which have important roles in the regulation of inflammation and insulin sensitivity. Although there is evidence of improvement in circulating levels of adipokines with weight loss, few studies relate such changes to specific diets. We investigated the effects of weight loss achieved by two different diets on circulating adipokine levels in obese individuals. Methods: A total of 120 obese patients (body mass index ≥ 35 kg/m2) underwent a three-month screening period on a low-fat, reduced-calorie diet. Patients failing to achieve a 5% weight loss using this approach were randomly allocated to either a low carbohydrate/high protein diet (n = 17) or to a commercial very low calorie diet (LighterLife®, n = 14) for a period of nine months. Results: At nine months, a significant weight loss was only maintained for Lighter-Life® (−32.3 ± 22.7 kg, P < 0.0001) but not on the low carbohydrate/high protein diet. Changes in adiponectin (15.8 ± 17.1 ng/mL versus −0.8 ± 6.2 ng/mL, P = 0.003) and leptin (−17.6 ± 24.3 ng/mL versus −3.0 ± 9.2 ng/mL, P = 0.049) at nine months were significantly greater for LighterLife® than for the low carbohydrate/high protein diet, which may reflect greater weight loss and decrease in fat mass. Changes in tumor necrosis factor-alpha, interleukin-6, and plasminogen activator inhibitor type 1 did not differ significantly between the dietary interventions at nine months. Conclusion: A significant weight loss of 23.8% from baseline weight was observed using a very low calorie diet and resulted in significant improvements in circulating levels of leptin, plasminogen activator inhibitor type 1, and adiponectin, which are likely to be due to weight loss and not macronutrient intake.

[1]  M. F. Quinn,et al.  The Counterweight programme: Prevalence of CVD risk factors by body mass index and the impact of 10% weight change. , 2008, Obesity research & clinical practice.

[2]  A. Greenberg,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Omental and Subcutaneous Adipose Tissues of Obese Subjects Release Interleukin-6: Depot Difference and Regulation by Glucocorticoid* , 1997 .

[3]  J. Helge,et al.  Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. , 2006, American journal of physiology. Endocrinology and metabolism.

[4]  G. Hallmans,et al.  Interrelationships between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein (a), and established cardiovascular risk factors in a north Swedish population. , 1989, Atherosclerosis.

[5]  S. Bahouth,et al.  Resistin release by human adipose tissue explants in primary culture. , 2003, Biochemical and biophysical research communications.

[6]  S. Toubro,et al.  Sustained improvement in blood lipids, coagulation, and fibrinolysis after major weight loss in obese subjects , 1998, European Journal of Clinical Nutrition.

[7]  K. Varady,et al.  Degree of weight loss required to improve adipokine concentrations and decrease fat cell size in severely obese women. , 2009, Metabolism: clinical and experimental.

[8]  T. Wadden,et al.  Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. , 1998, The Journal of clinical endocrinology and metabolism.

[9]  P. Eriksson,et al.  Leptin secretion from subcutaneous and visceral adipose tissue in women. , 1998, Diabetes.

[10]  F. Finelli,et al.  Origins of and Recognition of Micronutrient Deficiencies After Gastric Bypass Surgery , 2011, Current diabetes reports.

[11]  B. Thomas,et al.  Manual of dietetic practice , 2007 .

[12]  J. Chan,et al.  Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. , 2003, The Journal of clinical endocrinology and metabolism.

[13]  Peter Arner,et al.  Effects of different hypocaloric diets on protein secretion from adipose tissue of obese women. , 2004, Diabetes.

[14]  Z. Valenta,et al.  The decrease in C-reactive protein concentration after diet and physical activity induced weight reduction is associated with changes in plasma lipids, but not interleukin-6 or adiponectin. , 2006, Metabolism: clinical and experimental.

[15]  R. Ahima,et al.  Adipocytokine changes caused by low-carbohydrate compared to conventional diets in obesity. , 2005, Metabolic syndrome and related disorders.

[16]  J. Klein,et al.  Adipose tissue as source and target for novel therapies , 2006, Trends in Endocrinology & Metabolism.

[17]  T. Tai,et al.  Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. , 2001, The Journal of clinical endocrinology and metabolism.

[18]  E. Bruckert,et al.  Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. , 2002, The Journal of clinical endocrinology and metabolism.

[19]  M. Cnop,et al.  Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex , 2003, Diabetologia.

[20]  S. Rössner,et al.  Secretion of tumor necrosis factor-alpha shows a strong relationship to insulin-stimulated glucose transport in human adipose tissue. , 2000, Diabetes.

[21]  E. Muscelli,et al.  Overcoming metabolic syndrome in severe obesity: adiponectin as a marker of insulin sensitivity and HDL-cholesterol improvements after gastric bypass. , 2009, Arquivos brasileiros de endocrinologia e metabologia.

[22]  S. O’Rahilly,et al.  Congenital leptin deficiency is associated with severe early-onset obesity in humans , 1997, Nature.

[23]  C. Rolland,et al.  Randomized clinical trial of standard dietary treatment versus a low‐carbohydrate/high‐protein diet or the LighterLife Programme in the management of obesity * , 2009, Journal of diabetes.

[24]  T. Wadden,et al.  Short- and long-term changes in serum leptin dieting obese women: effects of caloric restriction and weight loss. , 1998, The Journal of clinical endocrinology and metabolism.

[25]  G. Pierer,et al.  Adipokine profile and insulin sensitivity in formerly obese women subjected to bariatric surgery or diet-induced long-term caloric restriction. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.

[26]  R. Judd,et al.  The influence of sex, body composition, and nonesterified fatty acids on serum adipokine concentrations. , 2009, Metabolism: clinical and experimental.

[27]  C. Ballantyne,et al.  Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction. , 2004, The Journal of clinical endocrinology and metabolism.

[28]  B. Zinman,et al.  Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus. , 1999, The Journal of clinical endocrinology and metabolism.

[29]  A. Rissanen,et al.  Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study. , 2008, European journal of endocrinology.

[30]  E. Rimm,et al.  Adiponectin and future coronary heart disease events among men with type 2 diabetes. , 2005, Diabetes.

[31]  E. Himeno,et al.  EFFECTS OF MILD AEROBIC EXERCISE AND A MILD HYPOCALORIC DIET ON PLASMA LEPTIN IN SEDENTARY WOMEN , 1999, Clinical and experimental pharmacology & physiology.

[32]  M. Alessi,et al.  Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus. , 1996, Annals of medicine.

[33]  U. Smith,et al.  Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. , 2001, Biochemical and biophysical research communications.

[34]  J. Argente,et al.  Evaluation of a multiplex assay for adipokine concentrations in obese children , 2010, Clinical chemistry and laboratory medicine.

[35]  E. Bruckert,et al.  Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. , 2000, The Journal of clinical endocrinology and metabolism.

[36]  Andrea Mari,et al.  Separate Impact of Obesity and Glucose Tolerance on the Incretin Effect in Normal Subjects and Type 2 Diabetic Patients , 2008, Diabetes.

[37]  D. Langin,et al.  Adipokines and dietary interventions in human obesity , 2010, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[38]  Steven B Heymsfield,et al.  Comparisons of waist circumferences measured at 4 sites. , 2003, The American journal of clinical nutrition.

[39]  E. Mannarino,et al.  The endocrine function of adipose tissue: an update , 2006, Clinical endocrinology.

[40]  J S Yudkin,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-�, in Vivo* , 2022 .

[41]  T Nakamura,et al.  Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[42]  R R Wing,et al.  Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.